Citations

Showing 10 of 108081 citations.

Clinical Information Retrieval: A literature review
Sivarajkumar, Sonish , Mohammad, Haneef Ahamed, Visweswaran, Shyam , Wang, Yanshan , Wang, Yanshan , Oniani, David , Roberts, Kirk E , Hersh, William , Liu, Hongfang , He, Daqing

Mayo Clinic

No container title available | April 3, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2748158/v1 Get It

Abstract Background: Clinical information retrieval (IR) plays a vital role in modern healthcare by facilitating efficient access and analysis of medical literature for clinicians and researchers. This scoping review aims to offer a comprehensive overview of the current state of clinical IR research and identify gaps and potential opportunities for future studies in this field. Objectives: The main objective of this review is to identify and analyze published research on clinical IR, including the methods, techniques, and tools used to retrieve and analyze clinical information from various sources. We aim to provide a comprehensive overview of the current state of clinical IR research and guide future research efforts in this field. Methods: We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and conducted a thorough search of multiple databases, including Ovid Embase, Ovid Cochrane Central Register of Controlled Trials, Ovid Cochrane Database of Systematic Reviews, Scopus, ACM Digital Library, IEEE Xplore, and Web of Science, from January 1st, 2012, to January 4th, 2023. The screening process involved multiple reviewers, and we included 184 papers for the final review. Results: We conducted a detailed analysis and discussion of various aspects of clinical IR research, including publication year, data sources, methods, techniques, evaluation metrics, shared tasks, and applications. Our analysis revealed key research areas in clinical IR, such as indexing, ranking, and query expansion, and identified opportunities for future research in these areas.
A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid Tumors
LaRose, Meredith, Connolly, Roisín M. , O’Sullivan, Ciara C. , Velcheti, Vamsidhar , Vilimas, Rasa , Gano, Katherine, Bates, Susan E. , Thomas, Anish , Bates, Susan E , Pommier, Yves G.

Mayo Clinic

The Oncologist | April 3, 2023 | Volume: 28 | Issue: 5 | Pages: 460-e298

10.1093/oncolo/oyad023 | PMID 37010988 Get It

Abstract Background Multiple preclinical studies have shown cytotoxic synergy involving combinations of poly (ADP-ribose) polymerase (PARP) inhibitors and topoisomerase 1 (TOP1) inhibitors, but such combinations have proven too toxic in clinical trials. Liposomal irinotecan (nal-IRI) achieved similar intratumoral exposure with better antitumor activity than the conventional TOP1 inhibitor irinotecan in preclinical models. Tumor targeted delivery of TOP1 inhibitor using nal-IRI and an intermittent schedule of administration of PARP inhibitor may provide a tolerable combination. Methods A phase I study was performed to evaluate the safety and tolerability of escalating doses of nal-IRI and the PARP inhibitor veliparib in patients with solid tumors resistant to standard treatments. Nal-IRI was administered on days 1 and 15 and veliparib on days 5-12 and 19-25 in 28-day cycles. Results Eighteen patients were enrolled across 3 dose levels. Five patients encountered dose–limiting toxicities, including grade 3 diarrhea lasting more than 72 h in 3 patients and 1 patient each with grade 4 diarrhea and grade 3 hyponatremia. The most common grade 3 or 4 toxicities included diarrhea (50% of patients), nausea (16.6%), anorexia, and vomiting (11.1% each) (Table 1). There was no difference in frequencies of adverse events based on UGT1A1*28 status or prior opioid use (Table 1). Conclusion The clinical trial was terminated due to high frequency of unacceptable gastrointestinal toxicities, which precluded dose escalation of veliparib in combination with nal-IRI (ClinicalTrials.gov Identifier: NCT02631733).
A Path to Real-World Evidence in Critical Care Using Open-Source Data Harmonization Tools
Heavner, Smith F. , Anderson, Wesley R., Dasher, Pamela, Weaver, Jeff, Schito, Marco , Kumar, Vishakha K. , Anderson, Wesley, Kashyap, Rahul , Dasher, Pam, Mathé, Ewy A. , Merson, Laura , Guerin, Philippe Jean , Robinson, Matthew L , Nagy, Paul G.

Mayo Clinic

Critical Care Explorations | April 3, 2023 | Volume: 5 | Issue: 4 | Pages: e0893

10.1097/cce.0000000000000893 | PMID 37025303 Get It

COVID-19 highlighted the need for use of real-world data (RWD) in critical care as a near real-time resource for clinical, research, and policy efforts. Analysis of RWD is gaining momentum and can generate important evidence for policy makers and regulators. Extracting high quality RWD from electronic health records (EHRs) requires sophisticated infrastructure and dedicated resources. We sought to customize freely available public tools, supporting all phases of data harmonization, from data quality assessments to de-identification procedures, and generation of robust, data science ready RWD from EHRs. These data are made available to clinicians and researchers through CURE ID, a free platform which facilitates access to case reports of challenging clinical cases and repurposed treatments hosted by the National Center for Advancing Translational Sciences/National Institutes of Health in partnership with the Food and Drug Administration. This commentary describes the partnership, rationale, process, use case, impact in critical care, and future directions for this collaborative effort.
Artificial intelligence and the aging mind
Lee, Jeyeon , Barnard, Leland R , Jones, David T.

Mayo Clinic

Aging | April 3, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.18632/aging.204644 | PMID 37014325 Get It

Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome
Joie, Renaud La , Thijssen, Elisabeth H. , Vento, Stephanie , Tsuei, Torie, Baker, Suzanne L. , Heuer, Hilary W. , Kramer, Joel H. , Ljubenkov, Peter A. , Rabinovici, Gil D. , Rosen, Howie, Staffaroni, Adam M. , Dickerson, Brad C., Huey, Edward D. , Dage, Jeffrey L. , Boxer, Adam L. , Boeve, Brad F, La Joie, Renaud , Rabinovici, Gil D , Dage, Jeffrey L , VandeVrede, Lawren , Asken, Breton M. , Cobigo, Yann , Fonseca, Corrina S. , Rojas, Julio C. , Boeve, Bradley F. , Grossman, Murray , Irwin, David J. , Litvan, Irene , Pantelyat, Alexander , Tartaglia, Maria Carmela

Mayo Clinic

JAMA Neurology | April 3, 2023 | Volume: 80 | Issue: 5 | Pages: 495

10.1001/jamaneurol.2023.0488 | PMID 37010841 Get It

ImportancePlasma phosphorylated tau217 (p-tau217), a biomarker of Alzheimer disease (AD), is of special interest in corticobasal syndrome (CBS) because autopsy studies have revealed AD is the driving neuropathology in up to 40% of cases. This differentiates CBS from other 4-repeat tauopathy (4RT)–associated syndromes, such as progressive supranuclear palsy Richardson syndrome (PSP-RS) and nonfluent primary progressive aphasia (nfvPPA), where underlying frontotemporal lobar degeneration (FTLD) is typically the primary neuropathology.ObjectiveTo validate plasma p-tau217 against positron emission tomography (PET) in 4RT-associated syndromes, especially CBS.Design, Setting, and ParticipantsThis multicohort study with 6, 12, and 24-month follow-up recruited adult participants between January 2011 and September 2020 from 8 tertiary care centers in the 4RT Neuroimaging Initiative (4RTNI). All participants with CBS (n = 113), PSP-RS (n = 121), and nfvPPA (n = 39) were included; other diagnoses were excluded due to rarity (n = 29). Individuals with PET-confirmed AD (n = 54) and PET-negative cognitively normal control individuals (n = 59) were evaluated at University of California San Francisco. Operators were blinded to the cohort.Main Outcome and MeasuresPlasma p-tau217, measured by Meso Scale Discovery electrochemiluminescence, was validated against amyloid-β (Aβ) and flortaucipir (FTP) PET. Imaging analyses used voxel-based morphometry and bayesian linear mixed-effects modeling. Clinical biomarker associations were evaluated using longitudinal mixed-effect modeling.ResultsOf 386 participants, 199 (52%) were female, and the mean (SD) age was 68 (8) years. Plasma p-tau217 was elevated in patients with CBS with positive Aβ PET results (mean [SD], 0.57 [0.43] pg/mL) or FTP PET (mean [SD], 0.75 [0.30] pg/mL) to concentrations comparable to control individuals with AD (mean [SD], 0.72 [0.37]), whereas PSP-RS and nfvPPA showed no increase relative to control. Within CBS, p-tau217 had excellent diagnostic performance with area under the receiver operating characteristic curve (AUC) for Aβ PET of 0.87 (95% CI, 0.76-0.98; P < .001) and FTP PET of 0.93 (95% CI, 0.83-1.00; P < .001). At baseline, individuals with CBS-AD (n = 12), defined by a PET-validated plasma p-tau217 cutoff 0.25 pg/mL or greater, had increased temporoparietal atrophy at baseline compared to individuals with CBS-FTLD (n = 39), whereas longitudinally, individuals with CBS-FTLD had faster brainstem atrophy rates. Individuals with CBS-FTLD also progressed more rapidly on a modified version of the PSP Rating Scale than those with CBS-AD (mean [SD], 3.5 [0.5] vs 0.8 [0.8] points/year; P = .005).Conclusions and RelevanceIn this cohort study, plasma p-tau217 had excellent diagnostic performance for identifying Aβ or FTP PET positivity within CBS with likely underlying AD pathology. Plasma P-tau217 may be a useful and inexpensive biomarker to select patients for CBS clinical trials.
Anesthetic Management and Deep Sedation After Emergence From General Anesthesia: A Retrospective Cohort Study
Deljou, Atousa , Soleimani, Jalal , Martin, David P. , Schroeder, Darrell R. , Schroeder, Darrell , Šprung, Juraj , Weingarten, Toby N.

Mayo Clinic

Anesthesia & Analgesia | April 3, 2023 | Volume: 136 | Issue: 6 | Pages: 1154-1163

10.1213/ane.0000000000006470 | PMID 37010956 Get It

BACKGROUND: Residual deep sedation during anesthesia recovery may predict postoperative complications. We examined the incidence and risk factors for deep sedation after general anesthesia. METHODS: We retrospectively reviewed health records of adults who underwent procedures with general anesthesia and were admitted to the postanesthesia care unit from May 2018 to December 2020. Patients were dichotomized by Richmond Agitation-Sedation Scale (RASS) score: ≤−4 (deeply sedated/unarousable) or ≥−3 (not deeply sedated). Anesthesia risk factors for deep sedation were assessed with multivariable logistic regression. RESULTS: Of the 56,275 patients included, 2003 had a RASS ≤−4 (35.6 [95% CI, 34.1–37.2] cases per 1000 anesthetics administered). On adjusted analyses, the likelihood of a RASS ≤−4 increased when more soluble halogenated anesthetics were used. Compared with desflurane without propofol, the odds ratio (OR [95% CI]) for a RASS ≤−4 was higher with sevoflurane (1.85 [1.45–2.37]) and isoflurane (4.21 [3.29–5.38]) without propofol. Compared with desflurane without propofol, the odds of a RASS ≤−4 further increased with use of desflurane-propofol (2.61 [1.99–3.42]), sevoflurane-propofol (4.20 [3.28–5.39]), isoflurane-propofol (6.39 [4.90–8.34]), and total intravenous anesthesia (2.98 [2.22–3.98]). A RASS ≤−4 was also more likely with the use of dexmedetomidine (2.47 [2.10–2.89]), gabapentinoids (2.17 [1.90–2.48]), and midazolam (1.34 [1.21–1.49]). Deeply sedated patients discharged to general care wards had higher odds of opioid-induced respiratory complications (2.59 [1.32–5.10]) and higher odds of naloxone administration (2.93 [1.42–6.03]). CONCLUSIONS: Likelihood of deep sedation after recovery increased with intraoperative use of halogenated agents with higher solubility and increased further when propofol was concomitantly used. Patients who experience deep sedation during anesthesia recovery have an increased risk of opioid-induced respiratory complications on general care wards. These findings may be useful for tailoring anesthetic management to reduce postoperative oversedation.
Women Representation in Anesthesiology Society Leadership Positions
McMullen, Kaley, McMullen, Kaley B, Harbell, Monica W. , Kosiorek, Heidi , Kraus, Molly B.

Mayo Clinic

Anesthesia & Analgesia | April 3, 2023 | Volume: 137 | Issue: 6 | Pages: 1171-1178

10.1213/ane.0000000000006465 | PMID 37010958 Get It

BACKGROUND: Although the number of women in medicine has increased, women remain underrepresented in leadership positions, specifically in medical societies. Specialty societies in medicine are influential in networking, career advancement, research and education opportunities, and providing awards and recognition. The goals of this study are to examine the representation of women in leadership positions in anesthesiology societies compared to women society members and women anesthesiologists and to analyze the trend in women society presidents over time. METHODS: A list of anesthesiology societies was obtained from the American Society of Anesthesiology (ASA) website. Society leadership positions were obtained via the societies’ websites. Gender was determined by images on the society website and images or pronouns on hospital websites and research databases. The percentage of women presidents, vice presidents/presidents-elect, secretaries/treasurers, board of directors/council members, and committee chairs was calculated. The percentage of women in society leadership positions was compared to the percentage of women society members when available, and the percentage of women anesthesiologists in the workforce (26%) using binomial difference of unpaired proportions tests. The trend of women presidents from 1980 to 2020 was analyzed using a Cochran-Armitage trend test. RESULTS: A total of 13 societies were included in this study. Overall, women held 32.6% (189/580) of leadership positions. 38.5% (5/13) of presidents, 17.6% (3/17) of presidents-elect/vice presidents, and 45% (9/20) of secretaries/treasurers were women. In addition, 30.0% (91/303) of board of directors/council members and 34.2% (90/263) of committee chairs were women. The percentage of women holding society leadership positions was significantly greater than the percentage of women anesthesiologists in the workforce ( P < .001), as was the percentage of women as committee chairs ( P = .003). The percentage of women society members was available for 9 of 13 societies (69%), and the percentage of women leaders was similar to the percentage of women society members ( P = .10). There was a significant difference in the percentage of women leaders between society size categories. Small societies had 32.9% (49/149) women leaders, medium had 39.4% (74/188) women leaders, and the single large society had 27.2% (66/243) ( P = .03). There were also significantly more women leaders in the Society of Cardiovascular Anesthesiologists (SCA) than there are women members ( P = .02). CONCLUSIONS: This study suggests that anesthesia societies may be more inclusive of women in leadership positions compared to other specialty societies. Although in anesthesiology, women remain underrepresented in academic leadership roles, there is a higher proportion of women in leadership roles in anesthesiology societies than proportion of women in the anesthesia workforce.
The Psychosocial Impact of the Kosovo War: A Systematic Review with Recommendations for Kosovar Patient Care
Vitija, Xheneta, Kelmendi, Fatjona, Pushani, Frosilda, Isak, Ergest, Ademaj, Amarildo, Jarrah, Ryan

Mayo Clinic

No container title available | April 3, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.168053402.28654642/v1 Get It

Introduction: The Kosovo War is widely remembered as one of the most brutal conflicts in the modern era. With over 13,000 deaths and 90% of the population displaced as refugees, the impact of the war has led to everlasting levels of trauma that impacts the lives of thousands of Kosovar-Albanians today. Objectives: To characterize the psychosocial impact of the Kosovo war by comprehensively assessing the literature to date. We also provide recommendations to improve outcomes for Kosovar-Albanian patients in the post-war era. Methods: A systematic review was conducted using post-war clinical psychological articles on the Kosovo War. Our search involved utilizing full-text English articles from PubMed, OVID Medline, and EMBASE journals. Keywords used were “Kosovo War”, “Psychosocial”, and “Post Traumatic Stress Disorder”. Results: Our post-traumatic stress disorder (PTSD) analysis yielded a total of 10,134 responses from participants ranging from refugees to the general public. Our results showed 2,997 subjects (30%) who reported or met the criteria for post-traumatic stress disorder. When analyzing refugee participants, there was 1,133 with 60% of them meeting the PTSD criteria. In a filtered cohort of 5,117 subjects measured for adverse events, 3,180 subjects (64%) of subjects had experienced combat, while 3,664 (74%) were exiled from their homes. Conclusion: The psychosocial impact of the Kosovo war is likely under-reported by patients due to cultural stigmas, language barriers, and trust barriers with clinicians. Factors such as age, employment, displacement status, number of traumatic events, socioeconomic vulnerability, and health literacy are associated with poor psychiatric morbidity.
Association of Weight Trajectory With Severe Obesity: A Case–Control Study
Skolnick, Victoria G. , Rajjo, Tamim , Kumar, Seema , Kaufman, Tara K. , Weaver, Amy L. , Lynch, Brian , Skolnick, Victoria , Thacher, Tom, Thacher, Tom D. , Wi, Chung‐Il

Mayo Clinic

Childhood Obesity | April 3, 2023 | Volume: 20 | Issue: 3 | Pages: 169-177

10.1089/chi.2023.0013 | PMID 37010378 Get It

Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead
Shin, Andrea , Kashyap, Purna

Mayo Clinic

Gut Microbes | April 3, 2023 | Volume: 15 | Issue: 1 | Pages: No page available

10.1080/19490976.2023.2195792 | PMID 37009874 Get It